Glenmark Pharmaceuticals Ltd

About

The late Gracias Saldanha founded Glenmark in 1977 to develop and market generic formulations. These formulations can now be spotted in geographies like the US, Europe, and Latin America. Its manufacturing facilities span the globe with 14 facilities spread across India, the US, Argentina, and the Czech Republic and focus on producing niche offerings, particularly in the fields of dermatology, respiration, and oncology. Other Glenmark products include those in the therapeutic areas of cardiovascular diseases and diabetes. Its first molecule research centre opened in Mahape, India, in the year 2000, after which it opened a biologics research centre in 2006 in Switzerland. Today, Glenmark collaborates with other companies, such as Forest Laboratories, for its small and biologics molecular research.